FUSED PYRIMIDINEONE COMPOUNDS AS TRPV3 MODULATORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120108813A1
SERIAL NO

13348219

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLENMARK PHARMACEUTICALS S ANot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHAUDHARI, Sachin Sundarlal Navi Mumbai, IN 16 61
KATTIGE, Vidya Ganapati Thane (W), IN 11 53
KHAIRATKAR-JOSHI, Neelima Thane (W), IN 58 205
LINGAM, Prasada Rao VS Navi Mumbai, IN 1 0
THOMAS, Abraham Navi Mumbai, IN 50 202

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation